Generex Biotechnology Corporation

OTCPK:GNBT Rapport sur les actions

Capitalisation boursière : US$61.0k

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Generex Biotechnology Gestion

Gestion contrôle des critères 2/4

Informations clés

Joe Moscato

Directeur général

n/a

Rémunération totale

Pourcentage du salaire du PDGn/a
Durée du mandat du directeur général5.4yrs
Propriété du PDG0.4%
Durée moyenne d'occupation des postes de direction5.4yrs
Durée moyenne du mandat des membres du conseil d'administration5.4yrs

Mises à jour récentes de la gestion

Recent updates

Analyse de la rémunération des PDG

Comment la rémunération de Joe Moscato a-t-elle évolué par rapport aux bénéfices de Generex Biotechnology?
DateRémunération totaleSalaireBénéfices de l'entreprise
Apr 30 2021n/an/a

-US$37m

Jan 31 2021n/an/a

-US$52m

Oct 31 2020n/an/a

-US$35m

Jul 31 2020US$623kUS$623k

-US$33m

Apr 30 2020n/an/a

-US$26m

Jan 31 2020n/an/a

-US$31m

Oct 31 2019n/an/a

-US$36m

Jul 31 2019US$103kn/a

-US$9m

Apr 30 2019n/an/a

US$10m

Jan 31 2019n/an/a

US$24m

Oct 31 2018n/an/a

US$27m

Jul 31 2018US$100kn/a

US$36m

Apr 30 2018n/an/a

US$9m

Jan 31 2018n/an/a

-US$37m

Oct 31 2017n/an/a

-US$43m

Jul 31 2017US$50kn/a

-US$70m

Rémunération vs marché: Insufficient data to establish whether Joe's total compensation is reasonable compared to companies of similar size in the US market.

Rémunération et revenus: Joe's compensation has increased whilst the company is unprofitable.


PDG

Joe Moscato (57 yo)

5.4yrs

Titularisation

US$623,082

Compensation

Mr. Joseph Moscato, also known as Joe, serves as Chief Executive Officer and Vice-Chairman of the Board at NuGenerex Immuno-Oncology, Inc. and served as its Chairman of the Board. Mr. Moscato has been the...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Joseph Moscato
CEO, President & Chairman of the Board5.4yrsUS$623.08k0.36%
$ 219.0
Mark Corrao
CFO & Treasurer5.4yrsUS$10.00k0%
$ 0
Terry Thompson
Chief Operating Officer4.4yrsUS$566.44k0%
$ 0
Andrew Ro
Chief Investment Officer & Director5.4yrsUS$18.88k0%
$ 0
Anthony Crisci
Chief Legal Officer & Chief Administrative Officer2.8yrsUS$424.83k0%
$ 0
Anthony Dolisi
Chief Commercial Officer3.4yrspas de données1.08%
$ 658.9
Jason Terrell
Chief Scientific Officer & Chief Medical Officer5.4yrspas de données0%
$ 0
Michelle Starr
Chief Marketing Officer3.6yrspas de donnéespas de données
Richard Purcell
Executive Vice President of Research & Drug Development5.4yrsUS$68.33k0%
$ 0

5.4yrs

Durée moyenne de l'emploi

56.5yo

Âge moyen

Gestion expérimentée: GNBT's management team is seasoned and experienced (5.4 years average tenure).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Joseph Moscato
CEO, President & Chairman of the Board5.4yrsUS$623.08k0.36%
$ 219.0
Andrew Ro
Chief Investment Officer & Director5.4yrsUS$18.88k0%
$ 0
Brian McGee
Independent Director18.3yrsUS$47.20k0%
$ 0
Lawrence Salvo
Independent Director5.4yrsUS$18.88k0.26%
$ 160.2
Craig Eagle
Independent Director & Member of Scientific Advisory Board11.8yrsUS$47.20k0%
$ 0
James Anderson
Independent Director11yrsUS$118.33k0%
$ 0
Gary Noel
Member of Scientific Advisory Board1.7yrspas de donnéespas de données
Mark Prioletti
Independent Director3.2yrspas de données0%
$ 0
John Sanders
Member of Scientific Advisory Board1.7yrspas de donnéespas de données
Jonathan Davis
Member of Scientific Advisory Board1.7yrspas de donnéespas de données

5.4yrs

Durée moyenne de l'emploi

59yo

Âge moyen

Conseil d'administration expérimenté: GNBT's board of directors are considered experienced (5.4 years average tenure).